Fisher & Paykel Healthcare’s (NZX: FPH) … [Read more...]
Fisher & Paykel’s F&P Nova Nasal Mask Now Available in US
Commentary: Embracing the Uniqueness of Every HME Patient
Studies are showing pushback from older patients taking GLP-1 medications.
In the early days of Mobility Management — the … [Read more...]
VieMed Q3 Earnings Call: Diversification, Lehan’s Acquisition Key to Strong Performance
Ventilation remains a VieMed cornerstone business, but made up less than half of the company’s net revenue.
VieMed Healthcare (Nasdaq: VMD) credited … [Read more...]
Resmed Launches AirTouch F30I Clear Full-Face Mask
The new CPAP mask is designed for comfort and to facilitate sleep.
Resmed’s latest full-face mask launch was made … [Read more...]
Research: US Obstructive Sleep Apnea Numbers to Rise Nearly 35% by 2050
A new study estimates 76.6 million adults in America, aged 30-69, will have OSA by then.
A new research study published in The Lancet … [Read more...]
Resmed Launches Clinically Focused Sleep Institute for Research, Education
The initiative aims to close a “system-wide gap in sleep health innovation.”
Resmed has launched a new, clinically focused … [Read more...]
New Research Focuses on Impact of Environment, Activities on Obstructive Sleep Apnea
Two new studies examined sleep data for more than 70,000 participants.
Two newly published research studies examine the … [Read more...]
Fisher & Paykel Launches ‘Powered by Curiosity’ Full-Face Mask Campaign
The manufacturer’s new focus follows marketing campaigns for its nasal and nasal pillows sleep apnea masks.
Fisher & Paykel Healthcare (NZX: FPH, OTC: … [Read more...]
Resmed CEO Mick Farrell Discusses Strong Q4 Results, Tariff Impact During Earnings Call
Resmed aims to support more than 500 million patients by 2030.
Resmed reported strong fourth-quarter fiscal year … [Read more...]
Philips Q2 Earnings Call Includes Respironics Update, Reports on Tariff Impact, Operations Simplifications
The company presented second-quarter financial results on July 29.
Updates on the impact of tariffs and Respironics’ … [Read more...]